AGROW’S TOP 20
Table1: Agrochemical sales
1
of the leading 20 companies, 2005-2006
Ranking Company US$ million
(2)
Recording currency (millions)
2006 2005 2006 2005 % change 2006 2005 % change
1 (1) Bayer CropScience
(3)
6,698 6,960 -3.8 €5,358 €5,568 -3.8
2 (2) Syngenta
(4)
6,378 6,330 +0.8 $6,378 $6,330 +0.8
3 (3) BASF 3,849 4,123 -6.6 €3,079 €3,298 -6.6
4 (4) Dow AgroSciences
(5)
3,399 3,364 + 1.0 $3,399 $3,364 + 1.0
5 (5) Monsanto
(6)
3,316 3,042 + 9.0 $3,316 $3,042 + 9.0
6 (6) DuPont
(7)
2,154 2,302 - 6.4 $2,154 $2,302 - 6.4
7 (7) MAI 1,581 1,543 + 2.5 $1,581 $1,543 + 2.5
8 (8) Sumitomo Chemical
(8)
1,312 1,292 + 1.5 ¥152,606 ¥142,277 + 7.3
9 (9) Nufarm
(9)
1,261 1,202 + 4.9 Aus$1,677 Aus$1,574 + 6.5
10 (10) Arysta LifeScience 941 906 + 3.9 ¥109,460 ¥99,778 + 9.7
11 (11) FMC 767 725 + 5.8 $767 $725 + 5.8
12 (12) Cheminova
(10)
604 597 + 1.2 DKr 3,588 DKr 3,575 + 0.4
13 (18) United Phosphorus
(8)
477 350 +36.3 $477 $350 +36.3
14 (16) Chemtura 360 354 + 1.7 $360 $354 + 1.7
15 (15) Isihara Sangyo Kaisha
(8)
359 368 -2.4 ¥41,800 ¥40,500 + 3.2
16 (13) Nissan Chemical
(8)
348 393 -11.5 ¥40,478 ¥43,277 -6.5
17 (14) Sipcam-Oxon
(11)
341 378 -9.8 € 273 €302 -9.6
18 (17) Kumiai Chemical
(12)
336 353 -4.8 ¥39,101 ¥38,835 +0.7
19 (19) Nippon Soda
(8)
312 337 -7.4 ¥36,245 ¥37,064 -2.2
20 (20) Nihon Nohyaku
(13)
302 308 -1.9 ¥35,075 ¥33,969 +3.3
Source: Agrow
Notes:
1
unless otherwise stated;
2
converted using average annual exchange rates for 2006 and 2005;
3
excludes BioScience sales of €342 million in 2006 and €328 million
in 2005;
4
excludes seed and plant science sales of US$1,745 million in 2006 and US$1,797 million in 2005;
5
includes undisclosed seed and trait sales;
6
year ended 31 August 2005/06 - includes some animal health products - excludes seed & genomics sales of US$4,028 million in 2006 and US$3,252 million in 2005;
7
excludes seed sales of US$2,764 million in 2006 and US$2,749 million in 2005;
8
year ended 31 March 2006/07;
9
year ended 31 July 2005/06;
10
excludes fine chemical and intermediate sales of some DKr 444 million in 2006 and DKr 442 million in 2005;
11
excludes intermediate and plant nutrition product sales of
some €17 million in 2006 and €33 million in 2005;
12
year ended 31 October 2005/06;
13
year ended 30 September 2005/06 - excludes landscaping and service revenues
of ¥1,759 million in 2006 and ¥1,384 million in 2005.
Herbicides and fungicides are BASF’s leading business and the company remains strong in At sixth place, Dupont Crop Protection recorded
product categories, accounting for 39% and 38% pesticides – it has patents for pest-resistant sales of US$2,154 million in 2006, which
of sales respectively. BASF is the market leader Bt crops. represented 7.9% of the company’s total turnover.
in non-GM herbicide-tolerant crops, with the Herbicides accounted for 60% of its 2006 sales but
Clearfield brand. However, BASF is developing GM Monsanto’s fifth place in the Agrow 2006 insecticides, particularly indoxacarb are growing
crops with agronomic and output traits and aims rankings was achieved with agrochemical sales in significance. Dupont is the leading producer
to become a leader in the field by 2010. It is also of US$3,316 million (this figure includes some of sulfonylurea herbicides. The company is also
strongly committed to the development of new animal health products). Its portfolio is dominated strong in ag biotech.
crop protection ais, particularly fungicides and by herbicides, especially glyphosate, which
insecticides. accounted for 68% of its agrochemical sales in Although analysts differ in their market estimates
2006, and 31% of the company’s total sales. for agrochemical sales in 2006, they are nearly all
Despite its sales remaining fairly static since 2004, Post patent, sales of glyphosate have done well in agreement that sales declined in most global
Dow AgroSciences held on to its fourth placing in and the company still has over 250 Roundup markets. Notable exceptions are China, which
Agrow’s top 20 rankings in 2006. The company formulation patents. ARN consultants say saw sales rise by 11.6% in
recorded agrochemical sales of US$3,399 million, dollar terms in 2006, and several countries in Latin
representing 6.9% of total company turnover. Monsanto’s strategy to shift the focus of its America, though Brazil recorded a poor year for
business from agrochemcials to seeds and agrochemicals overall.
Dow has been historically strong in herbicides, genomics continues to pay handsome dividends.
which remain the largest product category, Indeed, the company’s share price has almost Most analysts are cautiously optimistic for sales
accounting for around 54% of sales in 2006. doubled from 2006 to US$90 at the time of in 2007 – Cropnosis, for example, predicts an
In this category, the company has a promising writing. At present, Monsanto is the most increase of 1.4% over 2006, mainly on the back
pipeline of new ais, including herbicides that significant developer of GM crops, and varieties of higher insecticide and fungicide sales.
control weeds which are hard to control with containing its traits account for over 90% of the It expects the highest growth rate to
glyphosate. Biotechnology is a key part of its GM crops grown worldwide. occur in eastern Europe.
2 December 2007  •  www.agrow.com
Page 1  |  Page 2  |  Page 3  |  Page 4  |  Page 5  |  Page 6  |  Page 7  |  Page 8  |  Page 9  |  Page 10  |  Page 11  |  Page 12  |  Page 13  |  Page 14  |  Page 15  |  Page 16  |  Page 17  |  Page 18  |  Page 19  |  Page 20  |  Page 21  |  Page 22  |  Page 23  |  Page 24  |  Page 25  |  Page 26  |  Page 27  |  Page 28  |  Page 29  |  Page 30  |  Page 31  |  Page 32  |  Page 33  |  Page 34  |  Page 35  |  Page 36  |  Page 37  |  Page 38  |  Page 39  |  Page 40  |  Page 41  |  Page 42  |  Page 43  |  Page 44  |  Page 45  |  Page 46  |  Page 47  |  Page 48  |  Page 49  |  Page 50  |  Page 51  |  Page 52